Providence Medical Technology Launches Superiority Trial for CORUS-LX Lumbar Fusion System
Key Insights
Providence Medical Technology (search) has enrolled the first patients in a prospective randomized controlled trial evaluating the CORUS-LX System (search) for treating degenerative lumbosacral disease (search).
The multi-center superiority trial compares CORUS-LX combined with interbody fusion and pedicle screws against the current gold standard of interbody fusion with pedicle screws alone.
The study builds on the company's FUSE trial, which demonstrated superior composite fusion rates when adding CORUS PCSS (search) to anterior cervical fusion procedures.
Providence Medical Technology (search) has initiated enrollment in a prospective, randomized controlled trial evaluating its CORUS-LX System (search) for treating degenerative lumbosacral disease (search), marking a significant step toward challenging current standards in spinal fusion surgery. The multi-center study will enroll patients indicated for two-level interbody fusion with supplemental percutaneous pedicle screw fixation and posterior fusion.
Dr. Kade Huntsman of the Huntsman Spinal Clinic (search) in Salt Lake City, Utah, became the first clinical investigator to treat an enrolled subject with the study device. The case utilized a circumferential fusion approach, integrating lumbar interbody fusion with percutaneous pedicle screws and the CORUS-LX System (search) for fusion bed preparation and supplemental posterior stabilization and fusion. Huntsman joins Dr. Mohsin Fidai and Dr. Vivek Mohan as early-enrolling investigators in the study, which aims to evaluate subjects through 2027.
Building on Cervical Spine Success
This lumbar trial is designed to replicate the rigorous clinical validation established by Providence's FUSE study, which was the largest prospective RCT to evaluate three-level cervical fusion. Evidence from FUSE demonstrated that adding CORUS PCSS (search) to an anterior cervical fusion delivers clinically superior composite fusion rates to anterior fusion alone.
"The FUSE Study was a turning point for cervical spine surgery because it clearly demonstrated that tissue-sparing, supplemental posterior fixation improves patient outcomes for 3-level patients," said Scott Lynch, Chief Product Officer of Providence Medical Technology (search). "We believe this new trial will demonstrate that the CORUS-LX System (search) provides similar biological and mechanical advantages for the lumbar spine."
Pursuing Statistical Superiority
In a medical device market often focused on "non-inferiority," Providence is pursuing a statistical superiority endpoint. The trial aims to establish a new benchmark for two-level lumbar treatment options by comparing a treatment arm (CORUS-LX + Interbody Fusion + Pedicle Screws) against the current gold standard (Interbody Fusion + Pedicle Screws alone). The hypothesis is that the CORUS-LX construct will be a superior option for patients requiring L4-S1 (search) lumbar fusion.
The primary endpoint is to demonstrate superior 12-month composite fusion rates, with additional data collection on patient-reported outcomes and return-to-work measures through 24 months.
Addressing Fusion Bed Preparation Challenges
Percutaneous pedicle screws are commonly used to stabilize the spine as part of lumbar fusion surgery. While they offer a less invasive approach, percutaneous pedicle screws can limit a surgeon's ability to "decorticate" or prepare the bone for a solid fusion. The inability to thoroughly prepare the fusion bed can lead to higher rates of pseudarthrosis (search) (failure to fuse), particularly in high-risk patients.
The CORUS-LX System (search) provides a tissue-sparing solution that enables thorough decortication and precise bone graft delivery while providing the stability of a traditional screw. "Adding dedicated fusion implants in the facet joints (search) provides more places for bones to fuse — both front and back of the spine," said Dr. Huntsman. "We expect clinical results observed in the neck to extend to the lower back, with faster recovery and fewer fusion failures."
Integration with Surgical Navigation
A key component of the study involves using the CORUS-LX System (search) with modern surgical workflows, specifically the surgical navigation systems from Medtronic and Globus Medical. By combining CORUS-LX with these leading navigation systems, surgeons can achieve high-precision placement of posterior implants through a tissue-sparing corridor.
CORUS-LX is an integrated construct consisting of a stabilizer and two screws that is FDA-cleared for tissue-sparing posterior lumbar fusion and supplemental fixation. The system allows for extensive decortication and bone graft retention, serving as a dedicated fusion device that also provides significant stabilization.